Ethan Waisberg is an Academic Foundation Programme Doctor at the University of Cambridge, and Member of NASA’s Artificial Intelligence and Machine Learning Working Group.

His lifelong goal is to improve quality of life through vision research and clinical ophthalmology. Ethan helped develop a virtual-reality (VR) headset to perform various visual assessments on NASA astronauts during long-duration spaceflight that will be used on future NASA missions. Ethan's research has led to massive developments in the understanding of Spaceflight Associated Neuro-Ocular Syndrome (SANS), a condition that affects nearly 75% of astronauts, and is crucial to fully understand this condition prior to the mission to Mars. Ethan's research has been presented at The White House, United Nations, and World Health Organization. Ethan's research has been featured on international news such as the BBC, NY Post and The Times.

Ethan is also responsible for the Cambridge spin-out company AngioGenius, an App currently in development where anyone can take a photo of their eye at home to help detect and monitor eye disease progression. Using generative AI technology that Ethan's team previously developed to detect changes in the eyes of NASA astronauts, this simple photo of the eye can be turned into another imaging type that provides more rich data, allowing for the detection and monitoring of eye disease at home. This technology has already been scouted by the innovation arm of the UK's National Health Service.

Ethan is also currently writing the first textbook on space medicine technologies, which will be published with Elsevier and is titled: "Fundamentals of Space Medicine and Clinical Technology".